Company Filing History:
Years Active: 1977-1988
Title: The Innovations of Roland Reiner
Introduction
Roland Reiner is a prominent inventor based in Basel, Switzerland. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cephalosporin intermediates. With a total of 15 patents to his name, Reiner's work has had a substantial impact on medical science.
Latest Patents
One of Reiner's latest patents focuses on cephalosporin intermediates. This patent presents compounds of a specific formula wherein X represents the 1,2,5,6-tetrahydro-2-methyl-5,6-dioxo-as-triazin-3-yl group or its corresponding tautomeric form. The patent also details the readily hydrolyzable esters, ethers, and salts of these compounds, along with methods for their manufacture and corresponding pharmaceutical preparations. Another notable patent involves acyl derivatives, which includes compounds where R¹ is one of the 3-substituents usable in cephalosporin chemistry. This patent outlines various methods for the manufacture of these compounds and their derivatives.
Career Highlights
Roland Reiner is currently associated with Hoffmann-La Roche Inc., a leading company in the pharmaceutical industry. His work at this organization has allowed him to further his research and development efforts in innovative drug formulations.
Collaborations
Reiner has collaborated with notable colleagues such as Marc Montavon and Urs Weiss. Their combined expertise has contributed to the advancement of pharmaceutical innovations.
Conclusion
Roland Reiner's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a key innovator in the industry. His work continues to influence the development of important medical treatments.